The erythrosense as a real-time biomarker to reveal the presence of enhanced red blood cell aggregability in atherothrombosis

American Journal of Therapeutics

Volumn 12, Issue 4, 2005, Pages 286-292

  Rogowski, Ori ^a   Berliner, Shlomo ^a,b   Zeltser, David ^a   Serov, Jack ^a   Ben Assayag, Einor ^a   Justo, Daniel ^a   Rozenblat, Meirav ^a   Kessler, Anat ^a   Deutsch, Varda ^a   Zakuth, Vera ^a   Shapira, Itzhak ^a,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b Inflamet Ltd Company   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Anemia; Atherothrombosis; Erythrocyte adhesiveness aggregation; Inflammation

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; AGED; ANEMIA; ARTICLE; ATHEROSCLEROSIS; BLOOD RHEOLOGY; CELL ADHESION; CELL AGGREGATION; CONTROLLED STUDY; ERYTHROCYTE AGGREGATION; FEMALE; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; THROMBOSIS;

EID: 25844478513     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.00001= 26406.29484.9b     Document Type: Article

References (36)

1. Soutani M, Suzuki Y, Tateishi N, et al. Quantitative evaluation of flow dynamics of erythrocytes in microvessels: influence of erythrocyte aggregation. Am J Physiol. 1995;268:H1959-H1965.
2. Schmid-Schonbein H. Blood rheology and physiology of microcirculation. Ric Clin Lab. 1981;11(suppl 1):13-33.
3. Bishop JJ, Nance PR, Popel AS, et al. Effect of erythrocyte aggregation on velocity profiles in venules. Am J Physiol Heart Circ Physiol. 2001;280:H222-H236.
4. Mchedlishvili G, Gobejishvili L, Mamaladze A, et al. Microcirculatory stasis induced by hemorheological disorders: further evidence. Microcirculation. 1999;6:97-106.
5. Cabel M, Meiselman HJ, Popel AS, et al. Contribution of red blood cell aggregation to venous vascular resistance in skeletal muscle. Am J Physiol. 1997;272:H1020-H1032.
6. 2-permeable tube: effects of erythrocyte aggregation. Am J Physiol Heart Circ Physiol. 2001;281:H448-H456.
7. Klingel R, Fassbender C, Fassbender T, et al. Rheopheresis: rheologic, functional and structural aspects. Ther Apher. 2000;4:348-357.
8. Suckfull M, Hearing Loss Study Group. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet. 2002;360:1811-1817.
9. Berliner S, Rotstein R, Fusman R, et al. Increased erythrocyte adhesiveness/aggregation in the peripheral venous blood of patients with ischemic heart disease and an eventful course. Acta Cardiol. 2001;56:121-126.
10. Zeltser D, Bornstein NM, Rotstein R, et al. The erythrocyte adhesiveness/aggregation test in the peripheral blood of patients with ischemic brain events. Acta Neurol Scand. 2001;103:316-319.
11. Fusman R, Rotstein R, Zeltser D, et al. The state of leukocyte adhesiveness/aggregation in the peripheral blood of patients with type 2 diabetes and ischemic vascular disease. Acta Diabetol 2001;38:43-49.
12. Elishkewitch K, Fusman R, Kofler M, et al. Rheological determinants of red blood cell aggregation in diabetic patients in relation to their metabolic control. Diabet Med. 2002;19:152-156.
13. Fusman R, Rotstein R, Berliner S, et al. The concomitant appearance of aggregated erythrocytes, leukocytes and platelets in the peripheral blood of patients with risk factors for atherothrombosis. Clin Hemorheol Microcirc. 2001;25:165-173.
14. Anuk T, Ben Assayag E, Rotstein R, et al. Prognostic implications of admission inflammatory profile in acute ischemic neurological events. Acta Neurol Scand. 2002;106:196-199.
15. Deng LH, Barbenel JC, Lowe GD. Influence of hematocrit on erythrocyte aggregation kinetics for suspensions of red blood cells in autologous plasma. Biorheology. 2002;31:193-205.
16. Fabry TL. Mechanism of erythrocyte aggregation and sedimentation. Blood. 1987;70:1572-1576.
17. International Committee for Standardization in Hematology. Recommendation of measurement of erythrocyte sedimentation rate of human blood. Immunochemistry. 1965;2:235-254.
18. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol Basel. 1957;17:237-246.
19. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem. 1999;45:2136-2141.
20. Rogowski O, Zeltser D, Rotstein R, et al. Correlated expression of adhesive properties for both white and red blood cells during inflammation. Biorheology. 2000;37:361-370.
21. Fusman R, Zeltser D, Rotstein R, et al. INFLAMET: an image analyzer to display erythrocyte adhesiveness/aggregation. Eur J Intern Med. 2000;11:271-276.
22. Rotstein R, Fusman R, Zeltser D, et al. The picture of inflammation: a new concept that combines the white blood cell count and erythrocyte sedimentation rate into a new hematologic diagnostic modality. Acta Haematol. 2001;106:106-114.
23. Sharshun Y, Brill S, Mardi T, et al. Inflammation at a glance: erythrocyte adhesiveness/aggregation to reveal the presence of inflammation in individuals with atherothrombosis. Heart Dis. 2003;5:182-183.
24. Imaizumi K, Shiga T. Effect of immunoglobulins and IgG-fragments on the human erythrocyte aggregation, studied by rheoscope combined with image analyzer. Biorheology. 1983;20:569-577.
25. Weng X, Roederer GO, Beaulieu R, et al. Contribution of acute-phase proteins and cardiovascular risk factors to erythrocyte aggregation in normolipidemic and hyperlipidemic individuals. Thromb Haemost. 1998;80:903-908.
26. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;11:448-454.
27. Gamzu R, Rotstein R, Fusman R, et al. Increased erythrocyte adhesiveness and aggregation in peripheral venous blood of women with pregnancy-induced hypertension. Obstet Gynecol. 2001;98:307-312.
28. Weng X, Cloutier G, Beaulieu R, et al. Influence of acute-phase proteins on erythrocyte aggregation. Am J Physiol. 1996;271:H2346-H2352.
29. Engstrom G, Lind P, Hedblad B, et al. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation. 2002;105:2632-2637.
30. Ben Ami R, Barshtein G, Zeltser D, et al. Parameters of red blood cell aggregation as correlates of the inflammatory state. Am J Physiol Heart Circ Physiol. 2001;280:H1982-H1988.
31. Zeltser D, Rotstein R, Rogowski O, et al. The erythrocyte adhesiveness/aggregation (EAAT) in the peripheral blood of patients with ischemic heart and brain disease with normal fibrinogen concentrations. Appl Rheol. 2000;10:231-237.
32. Fusman G, Mardi T, Justo D, et al. Red blood cell adhesiveness/ aggregation, C-reactive protein, fibrinogen and erythrocyte sedimentation rate in healthy adults and in those with atherosclerotic risk factors. Am J Cardiol. 2002;90:561-563.
33. Rotstein R, Landau T, Twig A, et al. The erythrocyte adhesiveness/ aggregation test (EAAT). A new biomarker to reveal the low grade subclinical smoldering inflammation individuals with atherosclerotic risk factors. Atherosclerosis. 2002;165:343-351.
34. Sarnak MJ, Tighiouart H, Manjunath G, et al. Anemia as a risk factor for cardiovascular disease in the Atherosclerotic Risk Communities (ARIC) study. J Am Coll Cardiol. 2002;40:27-33.
35. Nissenson AR, Goodnough LI, Dubois RW. Anemia. Not just an innocent bystander? Arch Intern Med. 2003;163:1400-1404.
36. Papadaki HA, Kritikos HD, Valatas V, et al. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-a antibody therapy. Blood. 2002;100:474-482.